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EASILY MISSED?
Colorectal cancer
William Hamilton professor of primary care diagnostics 1, Mark G Coleman director and consultant
surgeon 2, Greg Rubin professor of general practice and primary care 3
1University of Exeter, Veysey Building, Exeter EX2 4SG, UK; 2Lapco National Training Programme in Laparoscopic Colorectal Surgery, Derriford
Hospital, Plymouth, UK; 3Durham University, Wolfson Research Institute, Stockton on Tees, UK
This is one of a series of occasional articles highlighting conditions that
may be more common than many doctors realise or may be missed at
first presentation. The series advisers are Anthony Harnden, university
lecturer in general practice, Department of Primary Health Care,
University of Oxford, and Richard Lehman, general practitioner, Banbury.
To suggest a topic for this series, please email us at
easilymissed@bmj.com.
A 72 year old recently widowed man presents to his general
practitioner with vague symptoms, including fatigue. Nothing
is found on examination, but his haemoglobin concentration is
114 g/L (range 140-180 g/L) with a hypochromic, normocytic
picture and serum ferritin 75 ng/mL (30-336 ng/mL). As his
diet has been poor since his wife died, he was treated with
ferrous sulphate, which was associated with a small
improvement in his fatigue and haemoglobin level. Six months
later he presented with intestinal obstruction, which was
subsequently found to be due to a carcinoma of the colon.
Surgically, the colon and rectum are distinct, but for the purposes
of this diagnostic article, they have been merged.
Why is colorectal cancer missed?
Many colorectal cancers are diagnosed easily and quickly and
times to diagnosis (generally measured as the diagnostic interval
from first presentation to primary care up to diagnosis) are less
than three months—particularly for patients whose clinical
features meet the referral guidelines of the National Institute
for Health and Clinical Excellence for suspected cancer.4
Symptoms include diarrhoea or rectal bleeding for six weeks
in patients aged more than 60, or for patients older than 40 if
both symptoms are present; rectal or abdominal masses or iron
deficiency anaemia with haemoglobin concentrations less than
110 g/L in men and less than 100 g/L in women. However,
about half of patients do not meet this guidance and have longer
diagnostic intervals.5Mortality from colorectal cancer is strongly
related to the first symptom, withmildly anaemic patients having
the worst prognosis; adjusted proportional hazard ratio compared
with all patients with colorectal cancer of 1.9 (95% confidence
interval 1.1 to 2.7).6 Audits from several countries suggest that
about a third of patients experience diagnostic delays, with
anaemia, rectal bleeding, and abdominal pain being the most
usual missed opportunities.7-9These three symptoms are common
in primary care, with alternative diagnoses to cancer more likely.
Furthermore, NICE guidance recommends urgent investigation
only for pronounced iron deficiency anaemia (haemoglobin
<110 g/L in men, and <100 g/L in women) or for persistent
rectal bleeding (six weeks, unless accompanied by diarrhoea).4
Additionally, the possibility of cancer may be dismissed in
patients with rectal bleeding and haemorrhoids.
Why does this matter?
A complex J-shaped relation exists between the diagnostic
interval and mortality.10 The best prognosis is for patients with
an interval of around one month, probably reflecting the timely
diagnosis of non-emergency patients. The high mortality with
shorter intervals probably represents obviously ill patients with
an inherently poor prognosis (including emergency admissions).
The prognosis steadily worsens with increasing intervals
thereafter. Expedited diagnosis may allow identification at an
earlier stage, or may obviate emergency admission.
How is colorectal cancer diagnosed?
The rest of this article assumes patients whomeet current NICE
guidance are investigated, and concentrates on presentations
that do not meet NICE guidelines.4 It does not concern factors
before presentation to medical care: there can be major delays
from patients not recognising that their symptoms are
important.11 We found no literature suggesting that colorectal
cancers in patients under 40 present differently from those in
older patients. Similarly, we found no primary care study of
colorectal cancer symptoms in patients with inflammatory bowel
disease.
Correspondence to: W Hamilton w.hamilton@exeter.ac.uk
For personal use only: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2013;346:f3172 doi: 10.1136/bmj.f3172 (Published 21 May 2013) Page 1 of 3
Practice
PRACTICE
Search strategy
WH and colleagues recently performed a systematic review of primary care symptoms of colorectal cancer.1 This was supplemented by
specific searches on missed or delayed diagnoses, plus searches on young people, irritable bowel syndrome, and inflammatory bowel
disease. No randomised controlled trials have been reported on the selection of patients for investigation, so most of the quoted studies are
large cohort studies, often using national primary care databases. Cited studies can be assumed to be of this nature unless specifically
stated otherwise.
How common is colorectal cancer?
• Colorectal cancer is the third most prevalent cancer in the United Kingdom, the incidence increasing with age, and it is slightly more
common in men
• More than 41 000 new cases of colorectal cancer are diagnosed annually in the United Kingdom, with the median age at diagnosis
72 years, although 6% occur below the age of 402
• Screening identifies a few patients with cancers; the remainder present with symptoms, with around a quarter presenting as an
emergency3
• A full time general practitioner will have around one patient with a new diagnosis of colorectal cancer each year
Anaemia
Around a third of patients with colorectal cancer in a hospital
case series had anaemia but of insufficient severity to meet
current NICE guidance, as in our hypothetical case.12 For those
meeting the guidance, the estimated risk of cancer in a large
UK case-control study was 13.3% for men and 7.7% for
women.13 The most common measure of iron stores is serum
ferritin level, with values below 44.9-67.4 pmol/L (20-30
ng/mL) being regarded as abnormal (individual laboratories
have differing ranges). However, in anaemic patients
investigated by colonoscopy, those with ferritin levels below
112.4 pmol/L and 112.4-222.5 pmol/L had a similar risk of
cancer.14 Together, this suggests that current guidance is too
restrictive. In men aged more than 60 with iron deficiency
anaemia, the risk of cancer with a haemoglobin concentration
of 110-119 g/L is over 4%; even haemoglobin values of 120-129
g/L represent risks of 3.9% in the 70-79 year age group.13 The
values for women reflect their lower normal haemoglobin range:
even so, the risk of cancer in women with haemoglobin
concentrations of 110-119 g/L is more than 2.4%. Raising the
haemoglobin threshold to allow investigation at such levels
would require more colonoscopies but would be in keeping with
the threshold risk values used by NICE for other colorectal
cancer symptom patterns.4
Abdominal pain
Abdominal pain is themost typical symptom of colorectal cancer
(alongside rectal bleeding) but it has a low positive predictive
value for colorectal cancer of 1.1%, although this increases to
3.0% if abdominal pain is reported again to primary care.15When
other symptoms, such as diarrhoea or loss of weight, are present,
the risk is higher, although rarely above 3%.15 Few patients with
abdominal pain are investigated for possible colorectal cancer
at their first presentation. One classic misdiagnosis is irritable
bowel syndrome. There is no causative association between
irritable bowel syndrome and colorectal cancer; however, around
1% of patients with an initial diagnosis of irritable bowel
syndrome prove to have colorectal cancer.16 All patients with a
new diagnosis of irritable bowel syndrome warrant clinical
review to confirm that their symptoms are stable and responding
to management (diagnostic safety netting). Some guidelines,
although not those from NICE, recommend that patients over
50 with new onset irritable bowel syndrome should undergo
colonoscopy.
Change in bowel habit and rectal bleeding
Change in bowel habit is a medical term, unused by patients. It
is not the same as diarrhoea or constipation, and the risk of
cancer is considerably higher when general practitioners’ record
“change of bowel habit” (3-4% in men aged >60) than when
they record diarrhoea (0.9-1.3%) or constipation (0.8%), in the
same age group.17 The most plausible explanation is that when
doctors record change in bowel habit they have included other
factors in their assessment and deem the total risk to be higher.
Arguably, all such patients warrant investigation.
Rectal bleeding is a classic symptom of colorectal cancer. In
primary care the risk of cancer ranges from 0.5% in women
aged less than 60 to 4.5% in men aged more than 80.17 The risk
is higher when diarrhoea is present or when local anal symptoms
such as pain, soreness, and itch are absent.18 A similar pattern
of higher risk with increasing age, multiple symptoms, and
absent perianal symptoms is seen in the referred population.19
The Association of Coloproctologists of Great Britain and
Ireland have developed a bowel symptom checker for the public
and for primary care (www.haveigotbowelcancer.com).
How is colorectal cancer investigated?
Complete examination of the large bowel by colonoscopy after
full bowel preparation remains the standard investigation for
patients suspected of having bowel cancer. Where colonoscopy
is incomplete (in around 11% of patients),20 it may be repeated,
or computed tomography colonography performed. Computed
tomography colonography has a similar identification rate for
cancer and polyps to that of colonoscopy, and both are superior
to barium enema.20 21 All the standard investigations have low
false negative rates, although persistent symptoms may require
reinvestigation.22
How is colorectal cancer managed?
National guidance on the management of colorectal cancer was
published in November 2011.23 Surgery, either open or
laparoscopic, is the primary treatment. Adjuvant treatments
include postoperative chemotherapy in patients with node
positive (Dukes’ stage C) results, and preoperative radiotherapy,
which reduces the risk of local recurrence in rectal cancer.
Metastases to the liver or lung may also be resected. Patients
presenting with large bowel obstruction can sometimes be
decompressed with an endoscopically placed stent, allowing
resection later.
We thank Eustacia Hamilton for help with the initial searches.
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Key points
• Patients with mild anaemia can still have colorectal cancer, even if their haemoglobin level is above the threshold recommended by
NICE for urgent investigation
• In people aged over 60, women with a haemoglobin concentration ≤110 g/L andmen ≤120 g/L and iron deficiency are worth investigating
for cancer
• Patients with a new diagnosis of irritable bowel syndrome should have their response to treatment monitored in case of misdiagnosis
• Doctors who record “change in bowel habit” rather than diarrhoea or constipation are potentially thinking of colorectal cancer and
further investigations should be considered
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